Tigerlogic Corp (TIGR) financial statements (2021 and earlier)
Company profile
| Business Address |
1532 SW MORRISON ST. PORTLAND, OR 97205 |
| State of Incorp. | DE |
| Fiscal Year End | March 31 |
| SIC | 7372 - Prepackaged Software (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 3/31/2015 | 3/31/2014 | 3/31/2013 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 10 | 19 | 6 | ||
| Cash and cash equivalents | 10 | 19 | 6 | ||
| Receivables | 1 | 1 | 1 | ||
| Prepaid expense and other current assets | ✕ | ✕ | 1 | ||
| Other current assets | 0 | 1 | ✕ | ||
| Other undisclosed current assets | 2 | ||||
| Total current assets: | 12 | 22 | 8 | ||
| Noncurrent Assets | |||||
| Property, plant and equipment | 1 | 1 | 1 | ||
| Intangible assets, net (including goodwill) | 0 | 19 | 32 | ||
| Goodwill | 18 | 32 | |||
| Intangible assets, net (excluding goodwill) | 0 | 1 | 1 | ||
| Other noncurrent assets | 0 | 0 | ✕ | ||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | 0 | ||
| Deferred tax assets, net | 0 | 0 | 0 | ||
| Total noncurrent assets: | 1 | 19 | 33 | ||
| TOTAL ASSETS: | 13 | 42 | 41 | ||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2 | 3 | 3 | ||
| Accounts payable | 0 | 0 | 0 | ||
| Accrued liabilities | 2 | 2 | 1 | ||
| Employee-related liabilities | 0 | 1 | 1 | ||
| Taxes payable | 0 | 0 | 0 | ||
| Deferred revenue and credits | 2 | 2 | 4 | ||
| Other undisclosed current liabilities | (1) | (1) | (1) | ||
| Total current liabilities: | 4 | 4 | 6 | ||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 0 | 0 | 0 | ||
| Other liabilities | 0 | 0 | 0 | ||
| Total noncurrent liabilities: | 0 | 0 | 0 | ||
| Total liabilities: | 4 | 4 | 6 | ||
| Stockholders' equity | |||||
| Stockholders' equity attributable to parent, including: | 10 | 38 | 35 | ||
| Additional paid in capital | 143 | 143 | 141 | ||
| Accumulated other comprehensive income | 2 | 2 | 2 | ||
| Accumulated deficit | (139) | (110) | (112) | ||
| Other undisclosed stockholders' equity attributable to parent | 3 | 3 | 3 | ||
| Total stockholders' equity: | 10 | 38 | 35 | ||
| TOTAL LIABILITIES AND EQUITY: | 13 | 42 | 41 | ||
Income statement (P&L) ($ in millions)
| 3/31/2015 | 3/31/2014 | 3/31/2013 | ||
|---|---|---|---|---|
| Revenues (Revenue, Net) | 7 | 5 | 13 | |
| Cost of revenue (Cost of Goods and Services Sold) | (1) | (1) | (2) | |
| Gross profit: | 6 | 5 | 11 | |
| Operating expenses | (36) | (17) | (16) | |
| Other undisclosed operating income | 1 | 1 | 2 | |
| Operating loss: | (29) | (11) | (3) | |
| Nonoperating income (expense) | 0 | (0) | 0 | |
| Foreign currency transaction gain, before tax | 0 | |||
| Other nonoperating income (expense) | 0 | (0) | 0 | |
| Loss from continuing operations before income taxes: | (29) | (11) | (3) | |
| Income tax expense (benefit) | (0) | 4 | (0) | |
| Net loss attributable to parent: | (29) | (7) | (3) | |
| Other undisclosed net income available to common stockholders, basic | 9 | |||
| Net income (loss) available to common stockholders, diluted: | (29) | 1 | (3) | |
Comprehensive Income ($ in millions)
| 3/31/2015 | 3/31/2014 | 3/31/2013 | ||
|---|---|---|---|---|
| Net loss: | (29) | (7) | (3) | |
| Comprehensive loss: | (29) | (7) | (3) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (0) | 9 | (0) | |
| Comprehensive income (loss), net of tax, attributable to parent: | (29) | 1 | (3) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.